MicroTech Medical (Hangzhou) Co., Ltd. provides diabetes management, diabetes treatment, and diabetes monitoring and treatment medical devices in China and internationally. The company offers Equil patch insulin pump systems; AiDEX and LinX continuous glucose monitoring systems; POCT analyzer systems; closed-loop artificial pancreas systems; blood glucose monitoring systems; Exactive Pro blood glucose, blood ketone, and uric acid monitoring system; API open platform; and diabetes digital management software. It also involved in scientific research and technical services; business services; wholesale and retail; manufacturing; and commercials business. MicroTech Medical (Hangzhou) Co., Ltd. was incorporated in 2011 and is headquartered in Hangzhou, the People's Republic of China.
Frequently asked questions
What sector does MicroTech Med (Hangzhou) Co (2235) operate in?
MicroTech Med (Hangzhou) Co belongs to the Healthcare sector and operates in the Medical Devices industry.
What is MicroTech Med (Hangzhou) Co (2235) current stock price?
As of the latest data, MicroTech Med (Hangzhou) Co stock price is HK$6.60, with a previous close of HK$6.58. MicroTech Med (Hangzhou) Co gained HK$0.02 in the last trading session, representing a 0.3% increase.
What is MicroTech Med (Hangzhou) Co (2235) current market capitalization?
MicroTech Med (Hangzhou) Co market cap is approximately 1.04 billion.
What is MicroTech Med (Hangzhou) Co (2235) EBITDA?
MicroTech Med (Hangzhou) Co EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 40.26 million.
Does MicroTech Med (Hangzhou) Co (2235) pay dividends?
No. MicroTech Med (Hangzhou) Co does not pay a dividend.
What is MicroTech Med (Hangzhou) Co (2235) beta (volatility) score?
MicroTech Med (Hangzhou) Co has a beta of 0.500, indicating lower volatility than the overall market.
